There were 10 screen failures, seven were due to estrogen receptor negative status on the diagnostic core biopsy, one patient was found to have distant metastatic disease, and two patients did not qualify to take anastrozole due to medical comorbidities. The gene discussed is ESR1; the disease is metastatic neoplasm.